Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).
about
Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Andrographis paniculata elicits anti-invasion activities by suppressing TM4SF3 gene expression and by anoikis-sensitization in esophageal cancer cellsPhase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinomaPhase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.Chemoradiotherapy and surgery for T4 esophageal cancer in Japan.A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: Preliminary results and literature review.Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer.Review of chemotherapeutic approaches for operable and inoperable esophageal squamous cell carcinoma.Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane.Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003).A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and metSevere hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinomaAn integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A).Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma.Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.Plasma ghrelin levels as a predictor of adverse renal events due to cisplatin-based chemotherapy in patients with esophageal cancer.Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis.Recent advancements in esophageal cancer treatment in Japan.Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
P2860
Q30244382-945A5CC9-F73E-4685-B962-1E818AF989C8Q36516573-AE07271B-3825-4883-AC7F-400C8694CBE7Q36940910-61F27484-A345-4BAB-A7AE-B2B1BEA5FE2EQ37142445-9446DD0D-494C-40AE-9808-DF6DDCD0BE72Q38316252-7CC8B35E-3AB1-4368-A3BE-29015650E59DQ38701979-E2494C43-2BAC-49E0-8EFF-E32388B8D4BDQ38801101-C093EA76-EBA9-40D4-8847-91A54F161918Q38998520-29311FB5-24E1-4D80-9375-7DCB92CE77DAQ39015041-6C4947BA-CCA8-44D3-BB3E-ADF5D403A449Q39252283-038DB83C-4761-4BC0-9D8B-E67AC238E667Q40559737-83D1A45D-7029-4412-8601-52E8729524DAQ41488053-773B907E-B8BF-4235-995E-BECBF2ED7748Q42428002-2E3F6DC0-7D0D-4D91-9806-E1C15E731AA6Q49982554-A8D92618-4CEA-4AE5-A46B-FEAF7606E940Q50553192-680BE1A1-8809-4D16-AE38-035CCCC2FFA3Q53140865-AD3D43D8-1A00-4875-91C5-40E41E1F0933Q53186226-86FF5E89-F799-4761-AE6B-4EBD60855831Q55516981-66A43CC2-59E4-4ECF-9A1B-B3732EF5A603Q55658098-514D3425-7C2F-4D57-92D7-C6D298D0238AQ58696797-C7401FAC-6163-4EFA-8A6B-193E2D6E58B2
P2860
Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@ast
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@en
type
label
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@ast
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@en
prefLabel
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@ast
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@en
P2093
P2860
P356
P1433
P1476
Phase I/II trial of 2-weekly d ...... esophageal cancer (JCOG0807).
@en
P2093
Akihisa Tomori
Hisayuki Matsushita
Hitoshi Kusaba
Japan Esophageal Oncology Group/Japan Clinical Oncology Group
Junki Mizusawa
Kazumasa Fujitani
Keisho Chin
Koichi Taira
Shiko Seki
P2860
P304
P356
10.1111/CAS.12486
P577
2014-09-01T00:00:00Z